MENU
GLUE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Monte Rosa Therapeutics (GLUE) Earnings Date & Reports
Monte Rosa Therapeutics Inc is a clinical-stage biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins... Show more
A.I. Advisor
published Earnings
GLUE is expected to report earnings to fall 43.30% to -24 cents per share on November 05
Q3'26
Est.
$-0.24
Q2'26
Missed
by $0.05
Q1'26
Missed
by $0.03
Q4'25
Missed
by $0.10
Q3'25
Beat
by $0.03
The last earnings report on August 06 showed earnings per share of -43 cents, missing the estimate of -37 cents. With 1.27M shares outstanding, the current market capitalization sits at 999.02M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 617 949-2643
Employees
150
Web
https://www.monterosatx.com